ZyCoV-D may find favour in 12-18 age group for COVID-19 vaccination in India: GlobalData
ZyCoV-D’s Phase III interim analysis has shown efficacy of 66.6 per cent and was conducted in over 28,000 subjects, including 1000…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Study finds drugs used to treat prostate cancer could help treat COVID-19
Research showed that treatment with the androgen-blocking drug enzalutamide reduced TMPRSS2 levels in lab cultures of human lung…
Lupin gets USFDA approval of sNDA for SOLOSEC (secnidazole) to treat trichomoniasis
SOLOSEC demonstrated a 92.2 per cent clinically and statistically significant cure rate for patients with trichomoniasis based on…
Clariant and India Glycols establish JV for renewable ethylene oxide derivatives
The joint venture combines IGL’s renewable bio-ethylene oxide derivatives business, which includes a multipurpose production…
Alembic Pharma gets USFDA final approval for Nitrofurantoin Capsules, USP (Macrocrystals)
The capsules are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of…
Sun Pharma launches ‘Sunkalp’ on the occasion of National Doctors’ Day
As a special tribute, announces various initiatives for the welfare of doctors, their families and the community
Scientists identify new way to target mutant protein that can cause deadliest of cancers
The mutated form of the RAS protein has been referred to as the “Death Star” because of its ability to resist treatments and is…
Zydus applies to DCGI for EUA to launch ZyCoV-D
The COVID-19 vaccine has been tested in adolescent population in the 12-18 years age group in India as well
Express Pharma July 2021
India's Foremost Pharma & Biotech Magazine ~ Equipping Progress
CIMS Medica hosts ninth edition of Healthcare Excellence Awards
Held on June 26, 2021, in a virtual awards ceremony, achievers from various domains such as healthcare practitioners, physicians,…